Albert Koong, MD
Enriched profileChief Scientific Officer, UT MD Anderson Cancer Center (effective June 1, 2026); Professor and Chair, Department of Radiation Oncology · The University of Texas MD Anderson Cancer Center
Albert Koong is Chief Scientific Officer, UT MD Anderson Cancer Center (effective June 1, 2026); Professor and Chair, Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 847 publications with 29,925 citations (h-index 91); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Radiation Oncology profiles in the FindMyKOL directory.
Data verified 17 Oct 2026
Overview
Updated 25 Oct 2026
Albert Koong, MD, PHD, is Chief Scientific Officer, UT MD Anderson Cancer Center (effective June 1, 2026) at The University of Texas MD Anderson Cancer Center. The public record shows 847 publications with 29,925 citations (h-index 91), centered on Advanced Radiotherapy Techniques, Pancreatic and Hepatic Oncology Research, Cancer, Hypoxia, and Metabolism. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 2 companies, 4 NIH-funded awards (2019–2026).
- Most recent indexed publication: 2026 · Nature materials
- Top research focus: Advanced Radiotherapy Techniques
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 292.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
Sponsor: Albert Koong
- Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)
Sponsor: Accuray Incorporated
Industry payments
Updated 25 Oct 2026
2 companies reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:
- Elekta, Inc.Program year20241 payment
- Siemens Medical Solutions USA, Inc.Program year20241 payment
NIH funding
Updated 25 Oct 2026
4 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Acquired Resistance to Therapy and Iron (ARTI) Center
University of Tx Md Anderson Can Ctr
FY2026$1,356,909U54CA274220 - The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
University of Tx Md Anderson Can Ctr
FY2026$572,667R01CA269565 - Tumor hypoxia promotes acquired resistance to radiation through ferroptosis inhibition
University of Tx Md Anderson Can Ctr
FY2026$301,681U54CA274220
Congress activity
Updated 25 Oct 2026
221 congress contributions (2003–2026) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract B083: Mutant KRAS cooperates with the hypoxic tumor microenvironment to drive immunosuppressive macrophages via a paracrine PGE2/GM-CSF axis
AACR (meeting unresolved)
AACR2026Co-author - Abstract B075: Young- and older-onset pancreatic cancers arise through distinct mechanisms: Insights from genomic and germline analyses
AACR (meeting unresolved)
AACR2025Co-author - Palliative Radiotherapy within the Last 30 Days of Life: A Multi-Site Review of Practice Patterns
ASTRO Annual Meeting
ASTRO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy.
Clinical cancer research
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyArticle1,050 citations2017
- 03Loss of PTEN facilitates HIF-1-mediated gene expressionPreprint843 citations2000
- 04Pancreatic tumors show high levels of hypoxiaArticle673 citations2000
- 05XBP1 Is Essential for Survival under Hypoxic Conditions and Is Required for Tumor GrowthArticle581 citations2004
Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/albert-koong-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
Editorial & leadership roles
journal and society appointments- Fellow
American College of Radiology (FACR)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗ - Fellow
American Society for Radiation Oncology (FASTRO)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
Media & interviews
press, podcasts and appearances- Getting to know UT MD Anderson Chief Scientific Officer Albert Koong
M.D., Ph.D. (Cancerwise)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mdanderson.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH